Perceptions on onchocerciasis and ivermectin treatment in rural communities in Uganda: implications for long-term compliance

International Health

Volumn 1, Issue 2, 2009, Pages 163-168

  Ndyomugyenyi, Richard ^a   Byamungu, Andrew ^a   Korugyendo, Rose ^b  

^a MINISTRY OF HEALTH   (Uganda)

^b Uganda Management Institute   (Uganda)

Author keywords

Ivermectin; Knowledge; Onchocerciasis; Patient compliance; Perceived severity; Uganda

Indexed keywords

IVERMECTIN;

ADULT; ADVERSE DRUG REACTION; ARTICLE; DISEASE SEVERITY; DIZZINESS; DROWSINESS; EDEMA; ENDEMIC DISEASE; FEMALE; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PATIENT COMPLIANCE; PERCEPTION; PRIORITY JOURNAL; PRURITUS; RURAL HEALTH CARE; RURAL POPULATION; UGANDA;

EID: 71649084664     PISSN: 18763413     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.inhe.2009.08.008     Document Type: Article

References (27)

1. Kipp W., and Bamuhiiga J. Onchodermal skin disease in a hyperendemic onchocerciasis focus in Western Uganda. Am J Trop Med Hyg 67 (2002) 475-479
2. Fischer P., Kip W., Bamuhiinga J., Binta-Kahwa J., Kiefer A., and Büttner D.W. Parasitology and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda. Trop Med Parasitol 44 (1993) 311-321
3. WHO. The importance of onchocercal skin diseases. Geneva: World Health Organization; 1995, TDR/ONCHO/95.1.
4. Amazigo U.O. Detrimental effects of onchocerciasis on marriage age and breast-feeding. Trop Geogr Med 46 (1994) 322-325
5. Okello D.O., Ovuga E.B., and Ogwal J.W. Dermatological problems of onchocerciasis in Nebbi district, Uganda. East Afr Med J 72 (1995) 295-298
6. Ovuga E.B., Okello D., Ogwal Okeng J.W., Orwortho N., and Opoka F.O. Social and psychological aspects of onchocercal skin disease in Nebbi district, Uganda. East Afr Med J 72 (1995) 449-453
7. World Bank. African Programme for Onchocerciasis Control: Programme Document. Committee of Sponsoring Agencies (1996), World Bank, Washington
8. Brieger W.R., Awedoba A.K., Eneanya C.I., Hagan M., Ogbuagu K.F., Okello D.O., et al. The effects of ivermectin on onchocercal skin disease and severe itching: results of multi-centre trial. Trop Med Int Health 3 (1998) 951-961
9. Winnen M., Plaisier A.P., Alley E.S., Nagelkerke N.J.D., van Oortmarssen G., Boatin B.A., et al. Can ivermectin mass treatments eliminate onchocerciasis in Africa?. Bull World Health Organ 80 (2002) 384-390
10. Richard F.O., Hopkins D.R., and Cupp E. Varying programmatic goals and approaches to river blindness. Lancet 255 (2000) 1663-1664
11. Burnham G., and Mebrahtu T. Review: The delivery of ivermectin (Mectizan). Trop Med Int Health 9 (2004) A26-44
12. Akogun O.B., Akogun M.K., and Audu Z. Community perceived benefits of ivermectin treatment in northeastern Nigeria. Soc Sci Med 50 (2000) 1451-1456
13. Emukah E.C., Osuoha E., Miri E.S., Onyenama J., Amazigo U., Obijuru C., et al. A longitudinal study of impact of repeated mass treatment on clinical manifestation of onchcoerciasis in Imo State, Nigeria. Am J Trop Med Hyg 70 (2004) 556-561
14. Ndyomugyenyi R., Tukesiga E., Büttner D.W., and Garms R. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda. Trop Med Int Health 9 (2004) 882-886
15. Vlassoff C., Weiss M., Ovuga E.B.L., Eneanya C., Nwel P.T., Babalola S.S., et al. Gender and the stigma of onchocercal skin disease in African. Soc Sci Med 50 (2000) 1353-1368
16. Dimomfu B.L., Kayembe D.L., Noma M., Sékétéli A., and Boussinesq M. African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan ®). Trans R Soc Trop Med Hyg 101 (2007) 674-679
17. Oladepo O., Brieger W.R., Otusanya S., Kale O.O., Offiong S., and Titiloye M. Farm land size and onchocerciasis status of peasant farmers in South-Western Nigeria. Trop Med Int Health 2 (1997) 334-340
18. Benton B., Bump J., Sékétéli A., and Liese B. Partnership and promise: evolution of the African river-blindness campaigns. Ann Trop Med Parasitol 96 Suppl (2002) S5-14
19. Nnoruka E.N., and Agu C.E. Successful treatment of scabies with oral ivermectin in Nigeria. Trop Doct 31 (2001) 15-18
20. Njoo F.L., Belling A.C., Oosting J., Vetter J.C., Stilma J.S., and Kijlsta A. Concurrent parasitic infections in onchocerciasis and the occurrence of adverse reactions after ivermectin treatment. Am J Trop Med Hyg 48 (1993) 652-657
21. Olsen A., Magnussen P., Ouma J.H., Andreassen J., and Friis H. The contribution of hookworm and other parasitic infections to haemoglobin and iron status among children and adults in western Kenya. Trans R Soc Trop Med Hyg 92 (1998) 643-649
22. Ndyomugyenyi R., Kabatereine N., Oslen A., and Magnussen P. Malaria and hookworm infections in relation to haemoglobin and serum ferritin levels in pregnancy in Masindi district, western Uganda. Trans R Soc Trop Med Hyg 102 (2008) 130-136
23. Brieger W.R., Otusanya S.A., Oke G.A., Oshinawe F.O., and Adeniyi J.D. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oya State, Nigeria. Trop Med Int Health 7 (2001) 11-18
24. Semiyaga N.B., Lalobo O., and Ndyomugyenyi R. Refusal to ivermectin treatment; the associated risk factors in Hoima district, Uganda. Ann Trop Med Parasitol 99 (2005) 659-667
25. Nuwaha F., Okware J., and Ndyomugyenyi R. Predictors of compliance with community-directed ivermectin treatment in Uganda: quantitative results. Trop Med Int Health 7 (2005) 659-667
26. Katabarwa N., Mutabazi D., and Richards F.O. Controlling onchocerciasis by community directed, ivermectin treatment programmes in Uganda: why do some communities succeed and others fail?. Ann Trop Med Parasitol 94 (2000) 343-352
27. Escott S., and Walley J. Listening to those on the frontline: Lessons for community-based tuberculosis programmes from a qualitative study in Swaziland. Soc Sci Med 61 (2005) 1701-1710